Ardea biosciences, inc. – product pipeline review – 2012
1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Ardea Biosciences, Inc. – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Market Direct’s pharmaceuticals report, “Ardea Biosciences, Inc. - Product
Pipeline Review - 2012” provides data on the Ardea Biosciences, Inc.’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Ardea Biosciences, Inc.’s corporate website, SEC filings,
investor presentations and featured press releases, both from Ardea Biosciences,
Inc. and industry-specific third party sources, put together by Global Markets
Direct’s team.
Scope
- Ardea Biosciences, Inc. - Brief Ardea Biosciences, Inc. overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Ardea Biosciences, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:
2. List of Tables 4
List of Figures 4
Ardea Biosciences, Inc. Snapshot 5
Ardea Biosciences, Inc. Overview 5
Key Information 5
Key Facts 5
Ardea Biosciences, Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Ardea Biosciences, Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Pipeline Products – Combination Treatment Modalities 10
Ardea Biosciences, Inc. – Pipeline Products Glance 11
Ardea Biosciences, Inc. – Late Stage Pipeline 11
Phase III Products/Combination Treatment Modalities 11
Ardea Biosciences, Inc. Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Ardea Biosciences, Inc. – Early Stage Pipeline Products 14
Pre-Clinical Products/Combination Treatment Modalities 14
Ardea Biosciences, Inc. – Drug Profiles 15
900 Series 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
RDEA3170 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
RDEA594 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
3. List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
Ardea Biosciences, Inc. – Product Pipeline Review – 2012
Astellas Pharma Inc. – Product Pipeline Review – 2012
Bayer AG – Product Pipeline Review – 2012
BioLineRx, Ltd. – Product Pipeline Review – 2012
Cytokinetics, Incorporated – Product Pipeline Review – 2012
Meda AB – Product Pipeline Review – 2012
Medivir AB – Product Pipeline Review – 2012
Nektar Therapeutics – Product Pipeline Review – 2012
Novo Nordisk A/S – Product Pipeline Review – 2012
SciClone Pharmaceuticals, Inc. – Product Pipeline Review – 2012
4. Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com
